Skip to main content

Oncology Startups

Updated November 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
313
Total Funding
$679.2M
Avg Funding
$27.2M
Global Reach
6
countries

Top Cities for Oncology

Closter
Tempe
Houston
Branford
San Francisco
San Carlos

Recently Funded Companies

Export
Closter, United States

Chemo Mouthpiece is an medical device company that develops and commercializes propriety oral cryotherapy products for cancer patients.

$900K raised
Nov 2024

Founder Contacts

41,000+ verified contacts

Tempe, United States

Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.

$785K raised
Nov 2024

Founder Contacts

41,000+ verified contacts

Houston, United States

At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.

$581K raised
Nov 2024

Founder Contacts

41,000+ verified contacts

Branford, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

$20.0M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

$92.0M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

$2.0M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

Atlanta, United States

OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.

$16.0M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

Amsterdam, The Netherlands

LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.

$21.9M raised
Oct 2024

Founder Contacts

41,000+ verified contacts

Boston, United States

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

$175.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

$13.4M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Baltimore, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

$4.5M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

$16.3M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Berkeley, United States

KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.

$150K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Hünenberg, Switzerland

CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.

$117K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Chicago, United States

CancerIQ provides a precision prevention platform that empowers community-based providers to prevent cancer.

Aug 2024

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Earli develops genetic constructs for early cancer detection and targeted therapy.

Aug 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

$120.0M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Hula Therapeutics is a pediatric oncology company.

$250K raised
Jul 2024

Founder Contacts

41,000+ verified contacts

Boston, United States

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

$150.0M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

Reims, France

Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.

$7.6M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

London, Canada

Tenomix's mission is to develop novel technologies that target inefficiencies in the pathology workflow and optimize cancer care.

$367K raised
Jul 2024

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom

Patient-centric cancer data and analytics platform for translational cancer biologists

Jul 2024

Founder Contacts

41,000+ verified contacts

Waltham, United States

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

$12.0M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

Liverpool, United Kingdom

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

$3.3M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Valar Labs offers assistance services for cancer treatment through Artificial Intelligence.

$22.0M raised
May 2024

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 313 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.

Average Funding
$27.2M
Total Funding Tracked
$679.2M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.London
3 companies$30.1M
2.Boston
2 companies$325.0M
3.Closter
1 companies$900K
4.Tempe
1 companies$785K
5.Houston
1 companies$581K

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

313 Oncology Startups (2026) — Recently Funded — Page 7 | VCBacked